Genomic locations of AR sites did not deviate between fibroblast‐unique sites and those AR sites observed in PCDFs and PCa cells, with the vast majority of AR binding observed in distal intergenic regions and introns, which is a typical feature of enhancers (Fig. 4E). The gene discussed is AR; the disease is posterior cortical atrophy.